Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations

References

• Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017–58.
   PubMed Web of Science ®Google Scholar
• Dullaart RPF, Groener JEM, Erkelens DW. Cholesteryl ester transfer between lipoproteins. Diab Nutr Metab 1991; 14: 329–43.
   Google Scholar
• Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255–74.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Rye KA. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol 1995; 6: 306–31.
   PubMedGoogle Scholar
• Jiang X-C, Bruce C, Mar J, Lin M, Francone OL, Tall AR. Targeted mutation of plasma phospho-lipid protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103: 907–14.
   Google Scholar
• Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Athero-sclerosis 2001; 155: 269–81.
   PubMed Web of Science ®Google Scholar
• Van Tol APhospholipid transfer protein. CUff Opin Lipidol 2002; 13: 135–9.
   PubMedGoogle Scholar
• Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-13-migrating high-density lipoprotein. Biochemistry 1988; 27: 25–9.
   PubMed Web of Science ®Google Scholar
• Van Haperen R, Van Tol A, Vermeulen P, Jauhiainen M, Van Gent T, Van Den Berg P, Ehnholm S, Grosveld F, Van Der Kamp A, De Crom R. Human plasma phospholipid transfer increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000; 20: 1082 — 8.
   PubMedGoogle Scholar
• Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phos-pholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032— 6.
   PubMedGoogle Scholar
• Lusa S, Jauhiainen M, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assman G. The mechanism of plasma lipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J 1996; 313: 275–82.
   PubMedGoogle Scholar
• Post SM, De Crom R, Van Haperen R, Van Tol A, Princen HMG. Increased fecal bile acid excretion in transgenic mice with elevated expres-sion of human phospholipid transfer protein. Arterioscler Thromb Vasc Biol 2003; 23: 892–7.
   PubMedGoogle Scholar
• Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyper-glycemia predict coronary heart disease events in middle-age patients with NIDDM. Diabetes 1997; 46: 1354–9.
   PubMed Web of Science ®Google Scholar
• Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester in non-insulin-dependent diabetes mellitus. Athero-sclerosis 1993; 104: 69–77.
   Google Scholar
• Elcheby M, Porokhov B, Pulcini T, Berthezene F, Ponsin G. Alterations in composition and con-centration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis 1996; 123: 93–101.
   Google Scholar
• Elcheby M, Pulcini T, Porokhov B, Berthezene F, Ponsin G. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes mellitus. Eur J Clin invest 1996; 26: 216–23.
   Google Scholar
• Riemens S, Van Tol A, Sluiter W, Dullaart RPF. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid trans-fer protein. Atherosclerosis 1998; 140: 71–9.
   PubMedGoogle Scholar
• Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Plasma phospholipid transfer protein acti-vity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia 1998; 41: 929— 34.
   PubMedGoogle Scholar
• Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Plasma phospholipid transfer protein acti-vity is lowered by 24-h insulin and Acipimox administration. Blunted response to insulin in type 2 diabetic patients. Diabetes 1999; 48: 1631–7.
   PubMedGoogle Scholar
• Riemens SC, Van Tol A, Scheek LM, Dullaart RPF. Plasma cholesteryl ester transfer and hepatic lipase activity are related to high density lipopro-tein cholesterol in association with insulin resis-tance in type 2 diabetic and non-diabetic subjects. Scand J Clin Lab Invest 2001; 61: 1–10.
   PubMedGoogle Scholar
• Mann CJ, Yen FT, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertrigly-ceridemia. J Clin Invest 1991; 88: 2059–66.
   Google Scholar
• Lottenberg SA, Lottenberg AMP, Nunes VS, McPherson R, Quintao ECR. Plasma cholesteryl transfer concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls. Atherosclerosis 1996; 127: 81–90.
   Google Scholar
• Kahn J, Syvanne M, Taskinen MR. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and with-out coronary heart disease. Metabolism 1994; 43: 1498–502.
   Google Scholar
• Passarelli M, Catanozi S, Nakandakare ER, Rocha JC, Morton RE, Shimabukuro AFM, Quintao ECR. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from apo-B-containing lipoproteins. Diabetologia 1997; 40: 1085— 93.
   Google Scholar
• McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991; 11: 797–804.
   Google Scholar
• Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737–44.
   PubMed Web of Science ®Google Scholar
• Van Venrooij FV, Stolk RP, Banga JD, Sijmondsma T, Van Tol A, Erkelens DW, Dallinga-Thie GM. DALI study group. Common cholesteryl ester protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diab Care 2003; 26: 1216–23.
   Google Scholar
• Desrumeaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L. Mass concentration of plasma phospholipid transfer protein in normolipidemic, Type Ha hyperlipidemic, Type lIb hyperlipidemic, and non-insulin-dependent diabetic subjects as mea-sured by a specific ELISA. Arterioscler Thromb Vasc Biol 1999; 19: 266–75.
   PubMedGoogle Scholar
• Oka T, Kujiraoka T, Ito M, Nagano M, Ishihara M, Iwasaki T, Egashira T, Miller NE, Hatori H. Measurement of human plasma phospholipid transfer protein by sandwich ELISA. Clin Chem 2000; 46: 1357–64.
   Google Scholar
• Huuskonen J, Ekstrom M, Tahvanainen E, Vainio A, Metso J, Pussinen P, Ehnholm C, Olkkonen VM, Jauhiainen M. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. Atherosclerosis 2000; 151: 451–61.
   Google Scholar
• Definition, diagnosis and classification of diabetes mellitus and its complications Report of a World Health Organization consultation. Part 1: diag-nosis and classification of diabetes mellitus (WHO/ NCD/NCS/99.2) 1999.
   Google Scholar
• Ostlund RE, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990; 322: 229— 34.
   Google Scholar
• Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810–7.
   PubMed Web of Science ®Google Scholar
• Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188–94.
   Google Scholar
• Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/ exchange activity in serum or plasma. Clin Chem 1986; 32: 283–6.
   Google Scholar
• Speijer H, Groener JEM, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159–68.
   Google Scholar
• Lie J, De Crom R, Van Gent T, Van Haperen R, Scheek L, Lankhuizen I, Van Tol A. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lipid Res 2002; 43: 1875–80.
   PubMedGoogle Scholar
• Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res 2000; 41: 1651–7.
   Google Scholar
• Murdoch SJ, Wolfbauer G, Kennedy H, Marcovina SM, Carr MC, Albers JJ. Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. J Lipid Res 2002; 43: 281–9.
   PubMedGoogle Scholar
• Karkkainen M, Oka T, Olkkonen VM, Metso J, Hattori H, Jauhiainen M, Ehnholm C. Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein. J Biol Chem 2002; 277: 15413–8.
   Google Scholar
• Bathnagar D, Durrington PN, Kumar S, Mackness MI, Boulton AJM. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus. Diab Med 1996; 13: 139–44.
   Google Scholar
• Lemkadem B, Loiseau D, Larcher G, Malthiery Y, Foussard F. Effect of nonenzymatic glycosyla-tion of high density lipoprotein-3 on the choles-teryl ester transfer protein activity. Lipids 1999; 34: 1281–6.
   Google Scholar
• Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 1984; 81: 2512–6.
   PubMedGoogle Scholar
• Morton RE. Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Curr Opin Lipidol 1999; 10: 321–7.
   PubMed Web of Science ®Google Scholar
• Gautier T, Masson D, Jong MC, Duverneuil L, Le Guern N, Deckert V, Pais de Banos JP, Dumont L, Bataille A, Zak Z, Jiang XC, Tall AR, Havekes LM, Lagrost L. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/apo CI-knocked out mice. J Biol Chem 2002; 277: 31354–63.
   Google Scholar
• Jonkers IJ, Smelt AH, Hattori H, Scheek LM, Van Gent T, De Man FH, Van Der Laarse A, Van Tol A. Decreased PLTP mass but elevated PLTP activity, linked to insulin resistance, in hypertriglyceridemia: effects of bezafibrate therapy. J Lipid Res 2003; 44: 1462–9.
   Google Scholar
• Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Acute and chronic effect of a 24-hour intravenous triglyceride challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. J Lipid Res 1999; 40: 1459–66.
   PubMedGoogle Scholar
• Murdoch SJ, Carr MC, Hokanson JE, Brunzell JD, Albers JJ. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res 2000; 41: 237–44.
   Google Scholar
• Kaser S, Sandofer A, Foger B, Ebenbichler CF, Igelseder B, Malaimare L, Paulweber B, Patsch JR. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetolo-gia 2001; 44: 1111–7.
   PubMedGoogle Scholar
• Riemens SC, Van To A, Stulp BK, Dullaart RPF. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorph-ism on plasma lecithin: cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999; 40: 1467–74.
   Google Scholar
• Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Tall AR. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 2001; 7: 847–52.
   Google Scholar
• Van Haperen R, Van To A, Van Gent T, Scheek L, Visser P, Van Der Kamp A, Grosveld F, De Crom R. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem 2002; 277: 48938–43.
   Google Scholar